Back to Urgent care

Tophaceous Gout Study Crystalys Therapeutics 302 – Dayton Area Study

Tophaceous Gout Study Flyer
Gout is the most common form of inflammatory arthritis. This study is a new medication for patients with gout experiencing palpable tophi (the subcutaneous deposits of uric acid crystals) or Tophaceous Gout.

Key criteria:

  • 18-75 yrs of age
  • BMI 18.5-45.0 (at least 110 lbs)
  • Diagnosed with gout at least one year
  • Have measurable tophus on hands/wrists and/or feet/ankles
  • Have experienced at least 2 documented gout flare ups in last 12 months
  • On stable allopurinol dose for at least 3 months (300-600mg)
Enrollment Form

Register for this Clinical Study

Submit your information below and someone from our research team will be in contact with you soon.

Date of Birth
I consent to receiving communication from Hometown Urgent Care and Research sent to the mobile number and/or e-mail that I have provided in this form. I have read and accept the Privacy Policy.